GO:0032197 retrotransposition: RNA-Mediated Genome Insertion, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032197 retrotransposition is a biological process in which a transposable element copies itself through an RNA intermediate that is reverse transcribed and inserted at a new genomic location.
• LINE-1 (L1) is the only autonomous protein-coding retrotransposon active in humans, and its deregulation is increasingly linked to cancer and genome instability.
• Retrotransposition is tightly controlled by host factors, including nuclear cGAS-TRIM41-mediated degradation of ORF2p and Schlafen-5 inhibition of LINE-1.
• In plants, retrotransposition is regulated by epigenetic pathways and small RNAs, as shown for Arabidopsis.
• Retrotransposition can drive disease-relevant genome rearrangements, including reciprocal translocations in human tumors.
• CRISPR-based knockout, knock-in, overexpression and library screening models enable functional dissection of retrotransposition regulators and their disease roles.
Description
Retrotransposition (GO:0032197) is a type of transposition in which a transposable element copies and pastes itself into a different genomic location via transcription of an RNA intermediate, reverse transcription into DNA, and insertion into the genome. This process is central to genome plasticity and has been studied across eukaryotes, from Arabidopsis to humans. Because retrotransposition can create new insertions, alter gene expression, and cause structural variation, it is a major topic in genomics, cancer biology, and developmental biology. In humans, the most studied autonomous retrotransposon is LINE-1 (L1), which encodes proteins required for its own mobilization and can also mobilize non-autonomous elements. Somatic L1 retrotransposition occurs in normal tissues and is increasingly recognized as a source of somatic mosaicism and disease-associated mutations. Concurrent L1 retrotransposition events have been linked to reciprocal translocations in tumorigenesis, highlighting the impact of this process on genome integrity. Host defense mechanisms, including nuclear cGAS and Schlafen-5, restrict L1 retrotransposition, demonstrating that cells actively suppress this process. Understanding retrotransposition therefore requires integrating molecular mechanisms, host regulation, and disease relevance.
retrotransposition At A Glance
| GO ID | GO:0032197 |
|---|---|
| GO term | retrotransposition |
| Ontology | biological_process |
| Synonym | Class I transposition; retrotransposon transposition; RNA-mediated transposition; Tf transposition; transposition, RNA-mediated; transposition via RNA intermediate; Ty1 element transposition; Ty2 element transposition; Ty3 element transposition; Ty element transposition |
| Major function | Copy-and-paste movement of transposable elements via an RNA intermediate and reverse transcription, enabling insertion into new genomic locations |
| Mechanistic class | RNA-mediated transposition (Class I transposon) |
| Key human element | LINE-1 (L1) is the only autonomous protein-coding retrotransposon active in humans |
| Host restriction | Nuclear cGAS promotes TRIM41-mediated ORF2p ubiquitination and degradation; Schlafen-5 inhibits LINE-1 retrotransposition |
| Disease link | L1 deregulation and concurrent retrotransposition events are associated with cancer and genome rearrangements |
What Is GO:0032197?
GO:0032197 retrotransposition is defined as a type of transposition in which a transposable element (transposon) copies and pastes itself into a different genomic location by transcription and conversion of the transcribed RNA back into DNA through reverse transcription. In other words, the element is first transcribed into RNA, then reverse transcribed into DNA, and the resulting DNA copy is inserted elsewhere in the genome. This RNA-mediated mechanism distinguishes retrotransposition from DNA-only cut-and-paste transposition and is the defining feature of Class I transposons, also called retrotransposons.
Why Is retrotransposition Important in Cell Biology?
Retrotransposition is important because it shapes genomes, generates somatic mosaicism, and can cause disease-associated mutations and structural rearrangements. In humans, L1 retrotransposition is deregulated in cancers and has been implicated in tumorigenesis through insertional mutagenesis and translocation formation. Host restriction factors such as nuclear cGAS and Schlafen-5 actively suppress L1, showing that retrotransposition is under active cellular control. In plants, retrotransposition is regulated by epigenetic and small RNA pathways, affecting genome stability and inheritance. Retrotransposition has also been linked to genomic imprinting and herpesvirus evolution, indicating broad biological impact beyond cancer. Studying retrotransposition therefore informs cancer biology, genome evolution, and host-pathogen interactions.
• Retrotransposition creates new genomic insertions and contributes to genome plasticity and evolution.
• L1 retrotransposition is deregulated in cancers and can promote tumorigenesis.
• Concurrent L1 retrotransposition events can promote reciprocal translocations in human tumors.
• Somatic L1 retrotransposition occurs in normal tissues and contributes to somatic mosaicism.
• Host factors such as nuclear cGAS and Schlafen-5 restrict L1 retrotransposition, revealing cellular defense mechanisms.
• In Arabidopsis, retrotransposition is regulated by epigenetic pathways, linking it to plant genome stability.
• Retrotransposition has been associated with genomic imprinting, affecting parent-of-origin gene expression.
• Retrotransposition has been implicated in herpesvirus evolution, showing relevance to viral genomics.
• Understanding retrotransposition supports development of therapeutic strategies targeting L1 in cancer.
• CRISPR models enable functional testing of retrotransposition regulators and their disease roles.
What Happens During retrotransposition?
Transcription of the retrotransposon
In simple terms: The retrotransposon is first copied into RNA.
Retrotransposition begins with transcription of the transposable element, producing an RNA intermediate that serves as the template for reverse transcription. For LINE-1, this RNA encodes the proteins required for mobilization, including ORF1p and ORF2p. The RNA intermediate is the defining feature that distinguishes retrotransposition from DNA-only transposition.
Reverse transcription and cDNA formation
In simple terms: The RNA is converted back into DNA.
The transcribed RNA is reverse transcribed into complementary DNA (cDNA) by the element-encoded reverse transcriptase, a key step in retrotransposition. For L1, ORF2p provides reverse transcriptase and endonuclease activities required for this process. This conversion of RNA back into DNA is the mechanistic core of GO:0032197.
Insertion into a new genomic location
In simple terms: The new DNA copy is pasted into a different place in the genome.
The cDNA copy is inserted into a new genomic location, often through target-primed reverse transcription and endonucleolytic cleavage of genomic DNA. This insertion can occur at many sites and can disrupt genes or regulatory elements. Concurrent insertion events can lead to structural rearrangements such as reciprocal translocations in tumors.
Host restriction and regulation
In simple terms: The cell has defense mechanisms that try to stop retrotransposition.
Host cells restrict retrotransposition through multiple mechanisms. Nuclear cGAS restricts L1 retrotransposition by promoting TRIM41-mediated ORF2p ubiquitination and degradation. Schlafen-5 inhibits LINE-1 retrotransposition, providing another layer of host defense. In Arabidopsis, retrotransposition is regulated by epigenetic pathways and small RNAs.
Somatic retrotransposition and mosaicism
In simple terms: Retrotransposition can happen in body cells, not just in eggs and sperm.
L1 retrotransposition occurs in somatic tissues, generating somatic mosaicism and potentially affecting gene expression in individual cells. Somatic retrotransposition has been detected in various normal tissues and is an active area of research. This somatic activity links retrotransposition to aging, cancer, and other disease processes.
Key Genes Involved in GO:0032197 retrotransposition
The following genes and proteins are central to retrotransposition, host restriction, and disease relevance, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LINE-1 (L1) | Autonomous human retrotransposon encoding ORF1p and ORF2p required for retrotransposition | Deregulated in cancers; target for therapeutic strategies |
| ORF1p | L1-encoded RNA-binding protein that forms ribonucleoprotein particles | Essential for L1 retrotransposition; biomarker in cancer studies |
| ORF2p | L1-encoded protein with endonuclease and reverse transcriptase activities | Catalyzes insertion; targeted by host restriction via TRIM41 |
| cGAS | Nuclear host factor that restricts L1 retrotransposition by promoting TRIM41-mediated ORF2p degradation | Innate immune sensor with nuclear functions in genome defense |
| TRIM41 | E3 ubiquitin ligase that mediates ORF2p ubiquitination and degradation | Host restriction factor for L1 retrotransposition |
| Schlafen-5 | Inhibits LINE-1 retrotransposition | Host defense factor; potential target for modulating L1 activity |
| Arabidopsis retrotransposons | Plant retrotransposons regulated by epigenetic pathways | Model for studying retrotransposition regulation in plants |
| Ty1 | Yeast retrotransposon used as a model for retrotransposition | Classic model system for mechanistic studies |
| Ty2 | Yeast retrotransposon related to Ty1 | Model for retrotransposition research |
| Ty3 | Yeast retrotransposon with distinct integration preferences | Model for studying integration site selection |
| Imprinted loci | Genomic regions affected by retrotransposition and imprinting | Link between retrotransposition and epigenetic regulation |
| Herpesvirus genes | Viral elements associated with retrotransposition in herpesvirus evolution | Evolutionary link between retrotransposition and viruses |
| Somatic L1 insertions | L1 insertions in somatic tissues | Source of somatic mosaicism and disease |
| Translocation-associated loci | Genomic regions involved in L1-mediated translocations | Cancer genome instability research |
How Is retrotransposition Regulated?
Retrotransposition is regulated at multiple levels. Host restriction factors such as nuclear cGAS promote TRIM41-mediated ubiquitination and degradation of ORF2p, limiting L1 retrotransposition. Schlafen-5 also inhibits LINE-1 retrotransposition, providing an additional restriction mechanism. In Arabidopsis, retrotransposition is controlled by epigenetic pathways and small RNAs. These regulatory layers ensure that retrotransposition is suppressed under normal conditions but can become deregulated in cancer and other diseases.
retrotransposition and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LINE-1 (L1) | Cancer, genome instability | Knockout of L1 in cancer cell lines; overexpression models |
| ORF2p | L1 retrotransposition, cancer | Point mutation of reverse transcriptase domain; tagged knock-in for imaging |
| cGAS | Host restriction of L1, innate immunity | Knockout and overexpression in human cells |
| TRIM41 | ORF2p degradation, L1 restriction | Knockout and point mutation of E3 ligase domain |
| Schlafen-5 | L1 inhibition | Overexpression and knockout models |
Retrotransposition in cancer
L1 retrotransposition is deregulated in cancers and has been implicated in tumorigenesis through insertional mutagenesis and genome instability. Concurrent L1 retrotransposition events can promote reciprocal translocations in human tumors, directly linking retrotransposition to structural rearrangements. These findings suggest that targeting L1 retrotransposition could offer therapeutic opportunities in cancer.
Somatic retrotransposition and mosaicism
L1 retrotransposition occurs in somatic tissues, generating somatic mosaicism that may contribute to aging and disease. Somatic insertions can alter gene expression in individual cells and may accumulate over time. This has implications for understanding cancer initiation and other age-related processes.
Retrotransposition and genomic imprinting
Retrotransposition has been linked to genomic imprinting, where parent-of-origin-specific gene expression is affected. Imprinted loci can be influenced by retrotransposon insertions, linking retrotransposition to epigenetic regulation. This connection highlights the broader impact of retrotransposition beyond cancer.
Retrotransposition and viral evolution
Retrotransposition has been associated with herpesvirus evolution, suggesting that retrotransposition-like processes can shape viral genomes. This evolutionary link underscores the broad relevance of retrotransposition across biological systems.
From retrotransposition-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene restrict L1 retrotransposition? | Knockout cell line followed by L1 retrotransposition reporter assay |
| Does a point mutation in ORF2p affect reverse transcription? | Point-mutation knock-in of ORF2p in human cells |
| Where does ORF2p localize during retrotransposition? | Tagged knock-in of ORF2p with fluorescent tag |
| Does overexpression of a host factor inhibit L1? | Overexpression cell model with L1 reporter |
| Which genes regulate retrotransposition in plants? | Arabidopsis knockout and overexpression lines |
| Can L1 retrotransposition be detected in somatic tissues? | Somatic tissue models and single-cell sequencing |
How to Study the retrotransposition Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Retrotransposition reporter assay | Frequency of retrotransposition events | Testing host factors and L1 activity |
| Insertion site sequencing | Genomic locations of new insertions | Mapping somatic and tumor insertions |
| Co-immunoprecipitation | Protein-protein interactions | Studying ORF2p-TRIM41 interaction |
| Ubiquitination assay | Protein degradation signals | Testing TRIM41-mediated ORF2p degradation |
| Small RNA sequencing | Small RNA populations | Analyzing retrotransposon regulation in plants |
| Single-cell sequencing | Somatic insertions in individual cells | Detecting mosaicism |
| Long-read sequencing | Structural variants and insertions | Detecting translocations |
| CRISPR screening | Genes affecting retrotransposition | Identifying novel regulators |
Retrotransposition reporter assays
Reporter assays are widely used to measure retrotransposition activity, often using a cassette that expresses a marker only after retrotransposition. These assays can be performed in human cell lines to test the effect of host factors such as cGAS and Schlafen-5. They are essential for functional studies of L1 and other retrotransposons.
Genomic insertion site mapping
Mapping insertion sites using sequencing-based methods allows researchers to identify where retrotransposons insert in the genome. This is important for understanding insertional mutagenesis and structural rearrangements such as translocations. Long-read sequencing and targeted approaches can detect somatic insertions.
Protein interaction and degradation studies
Co-immunoprecipitation and ubiquitination assays can reveal how host factors such as TRIM41 interact with ORF2p and promote its degradation. These methods help define the molecular mechanisms of host restriction. Proteomic approaches can identify additional regulators of retrotransposition.
Epigenetic and small RNA analysis
In plants, small RNA sequencing and epigenetic profiling are used to study retrotransposition regulation. These methods reveal how chromatin and RNA pathways control retrotransposon activity. Similar approaches can be applied in other systems.
How CRISPR Can Be Used to Study GO:0032197 retrotransposition
Knockout
CRISPR knockout of candidate host restriction genes such as cGAS, TRIM41, or Schlafen-5 can test whether they suppress L1 retrotransposition. Knockout of L1 itself in cancer cell lines can reveal its role in tumorigenesis. These models are essential for causal inference.
Point Mutation
Point mutations in ORF2p can dissect the catalytic residues required for reverse transcription and endonuclease activity. Point mutations in TRIM41 can test its E3 ligase activity in ORF2p degradation. These models provide mechanistic insights.
Knock-in
Tagged knock-in of ORF2p allows visualization and tracking of retrotransposition intermediates. Knock-in of reporter cassettes enables sensitive detection of retrotransposition events. These models are valuable for imaging and biochemical studies.
Overexpression
Overexpression of host factors such as Schlafen-5 or cGAS can test their ability to inhibit L1 retrotransposition. Overexpression of L1 itself can drive retrotransposition in otherwise restrictive cells. These models help define dosage effects.
How EDITGENE Supports retrotransposition Research
Researchers studying retrotransposition-related genes often need to determine whether a candidate gene is causally involved in restricting or promoting retrotransposition. EDITGENE provides CRISPR-based cell models and screening services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for retrotransposition research.
Frequently Asked Questions About retrotransposition
What is retrotransposition GO:0032197?
Retrotransposition is a biological process in which a transposable element copies and pastes itself into a new genomic location via an RNA intermediate that is reverse transcribed into DNA.
What genes are involved in retrotransposition?
Key genes include LINE-1 (L1), ORF1p, ORF2p, cGAS, TRIM41, and Schlafen-5, among others.
How is retrotransposition regulated?
It is regulated by host restriction factors such as nuclear cGAS-TRIM41 and Schlafen-5, as well as epigenetic pathways in plants.
What is the difference between retrotransposition and DNA transposition?
Retrotransposition uses an RNA intermediate and reverse transcription, while DNA transposition moves DNA directly.
Is retrotransposition linked to cancer?
Yes, L1 retrotransposition is deregulated in cancers and can promote genome instability and translocations.
What is LINE-1 retrotransposition?
LINE-1 is the only autonomous protein-coding retrotransposon active in humans, and its retrotransposition requires ORF1p and ORF2p.
How do host cells restrict retrotransposition?
Host cells use factors like cGAS, TRIM41, and Schlafen-5 to degrade ORF2p or otherwise inhibit L1 retrotransposition.
Can retrotransposition occur in somatic cells?
Yes, L1 retrotransposition occurs in somatic tissues and contributes to somatic mosaicism.
What methods are used to study retrotransposition?
Reporter assays, insertion site sequencing, co-immunoprecipitation, and CRISPR screens are commonly used.
How can CRISPR help study retrotransposition?
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional testing of genes involved in retrotransposition.
Conclusion
GO:0032197 retrotransposition is a fundamental biological process that shapes genomes through RNA-mediated copy-and-paste insertion. Its deregulation is linked to cancer and genome instability, while host factors such as cGAS, TRIM41, and Schlafen-5 restrict its activity. CRISPR-based models provide powerful tools to dissect the mechanisms and disease relevance of retrotransposition, supporting both basic research and therapeutic development.
References
- 1. Mendez-Dorantes C et al.. 2023. LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities.. Genes Dev 37(21-24):948-967 PMID: 38092519
- 2. Lee SC et al.. 2021. Regulation of retrotransposition in Arabidopsis.. Biochem Soc Trans 49(5):2241-2251 PMID: 34495315
- 3. Zumalave S et al.. 2026. Concurrent L1 retrotransposition events promote reciprocal translocations in human tumorigenesis.. Science 392(6793):eaee4513 PMID: 41747018
- 4. Zhen Z et al.. 2023. Nuclear cGAS restricts L1 retrotransposition by promoting TRIM41-mediated ORF2p ubiquitination and degradation.. Nat Commun 14(1):8217 PMID: 38086852
- 5. Cowley M et al.. 2010. Retrotransposition and genomic imprinting.. Brief Funct Genomics 9(4):340-6 PMID: 20591835
- 6. Brunovskis P et al.. 1995. Retrotransposition and herpesvirus evolution.. Virus Genes 11(2-3):259-70 PMID: 8828151
- 7. Faulkner GJ et al.. 2018. L1 retrotransposition in the soma: a field jumping ahead.. Mob DNA 9:22 PMID: 30002735
- 8. Ding J et al.. 2023. Schlafen-5 inhibits LINE-1 retrotransposition.. iScience 26(10):107968 PMID: 37810251
